Kazemi, A., Abroun, S., & Soleimani, M. (2021). AntagomiR-19a Induced Better Responsiveness to Bortezomib in Myeloma Cell Lines. Royan Institute (ACECR), Tehran.
Cita Chicago Style (17a ed.)Kazemi, Azam, Saeid Abroun, y Masoud Soleimani. AntagomiR-19a Induced Better Responsiveness to Bortezomib in Myeloma Cell Lines. Royan Institute (ACECR), Tehran, 2021.
Cita MLA (8a ed.)Kazemi, Azam, et al. AntagomiR-19a Induced Better Responsiveness to Bortezomib in Myeloma Cell Lines. Royan Institute (ACECR), Tehran, 2021.
Precaución: Estas citas no son 100% exactas.